Open an account

Advanced Biomedical Technologies

ABMT · OTC

$0.0005+$0.0095 (−105.56%)TodayMarket closed ·
No price history for this range.

About ABMT

Advanced BioMedical Technologies, Inc. engages in the business of designing, developing, manufacturing, and marketing biomaterial internal fixation devices. The company is headquartered in New York City, New York. The company went IPO on 2007-09-10. The Company’s primary products include Polymer Osteosynthesis Devices made of a proprietary material compositing of polyamide 6 (PA6), hydroxyapatite (HA) and poly (methyl methacrylate-co-N-vinylpyrrolidone) (P(MMA-co-NVP)). These advanced materials are used in surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, and reconstructive dental procedures. Its PA Binding Wires are under clinical trials and its PA Mini-Screws are under animal test.

Employees
0
Headquarters
New York City, New York
Listed
Sep 10, 2007
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
abtlafleur.com

ABMT key statistics

Market cap
50.00K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
1.77K
Volume
1
Open price
$0.0005
High today
$0.0005
Low today
$0.0005
52 Week high
$0.0005
52 Week low
$0.0001

Advanced Biomedical Technologies (ABMT) at a glance

As of Sep 24, 2026, Advanced Biomedical Technologies (ABMT) shares are priced at $0.0005, giving the company a market cap of 50.00K and a price-to-earnings ratio of 0.00.

Volume so far is 1 shares, below the average of 1.77K shares a day.

Over the past year Advanced Biomedical Technologies has ranged from $0.0001 to $0.0005, and now sits 100% of the way up that range.

Similar companies

Companies in the same industry as Advanced Biomedical Technologies

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.